ArticleEnvironmental science and ecotechnology2026
Molecular oxygen confinement ladder enables stable electro-Fenton treatment of nanofiltration concentrate.
Article in Environmental science and ecotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clean water scarcity intensifies the need for advanced treatment of emerging contaminants in nanofiltration (NF) concentrates. Conventional electro-Fenton (EF) systems face unstable oxygen supply and electrode wetting in bubbleless aeration, limiting selective reactive oxygen species generation in high-salinity matrices. Here we show a molecular oxygen confinement ladder strategy by developing a conductive aeration membrane cathode in which boron nitride spontaneously forms wedge-shaped structures inside carbon nanotubes. This architecture achieves kinetic antiwetting and physical oxygen confinement at the nanoscale, accelerating Fe(II)/Fe(III) cycling and directing the pathway to dominant singlet oxygen (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.